Right Ventricular Function During Exercise in Highlanders/Lowlanders

Sponsor
University of Zurich (Other)
Overall Status
Completed
CT.gov ID
NCT03165032
Collaborator
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov (Other)
173
1
2.8
62.7

Study Details

Study Description

Brief Summary

The purpose of the current study is to evaluate the right ventricular function during graded cycling on an ergometer by transthoracic echocardiography in Kyrgyz highlanders with high altitude pulmonary hypertension (HAPH) by performing a cross-sectional case-control study.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    173 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Right Ventricular Function During Exercise in Highlanders With Pulmonary Hypertension Compared to Highlanders Without Pulmonary Hypertension and Lowlanders
    Actual Study Start Date :
    May 24, 2017
    Actual Primary Completion Date :
    Aug 16, 2017
    Actual Study Completion Date :
    Aug 16, 2017

    Arms and Interventions

    Arm Intervention/Treatment
    High altitude pulmonary hypertension

    Highlanders with high altitude pulmonary hypertension living above 2500 m.

    High altitude control

    Healthy highlanders living above 2500 m.

    Low altitude control

    Healthy lowlanders living below 1000 m.

    Outcome Measures

    Primary Outcome Measures

    1. pulmonary artery pressure (PAP) during exercise [Day 2]

      Difference in change of tricuspid pressure gradient during exercise between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders, measured by transthoracic echocardiography during graded cycling on an ergometer

    Secondary Outcome Measures

    1. cardiac output (CO) during exercise [Day 2]

      Difference in change of cardiac output during exercise between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders, measured by transthoracic echocardiography during graded cycling on an ergometer

    2. PAP/CO slope during exercise [Day 2]

      Difference in change of PAP/CO slope during exercise between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders, measured by transthoracic echocardiography during graded cycling on an ergometer

    3. Oxygen saturation [Day 2]

      Difference in change of oxygen saturation during exercise between highlanders with pulmonary hypertension, healthy highlanders and healthy lowlanders, measured by transthoracic echocardiography during graded cycling on an ergometer

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    16 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • high altitude pulmonary hypertension confirmed by clinical presentation and mean pulmonary artery pressure >30 mmHg measured by echocardiography at altitude of residence.

    • healthy subjects (high altitude controls)

    • Both genders

    • Age >16 y

    • Kyrgyz ethnicity

    • born, raised and currently living at >2500 m

    • healthy subjects currently living at <1000 m (low altitude controls)

    Exclusion Criteria:
    • Pulmonary hypertension from other causes, in particular from left ventricular failure as judged clinically and by echocardiography

    • Excessive erythrocytosis

    • Other coexistent disorders that may interfere with the cardio-respiratory system and sleep

    • Regular use of medication that affects control of breathing

    • Heavy smoking

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Center for Cardiology and Internal Medicine Bishkek Kyrgyzstan 720040

    Sponsors and Collaborators

    • University of Zurich
    • National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Silvia Ulrich Somaini, Prof. Dr., University of Zurich
    ClinicalTrials.gov Identifier:
    NCT03165032
    Other Study ID Numbers:
    • 01-8/433B
    First Posted:
    May 24, 2017
    Last Update Posted:
    Aug 16, 2019
    Last Verified:
    Aug 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Silvia Ulrich Somaini, Prof. Dr., University of Zurich
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 16, 2019